Clinical and Radiographic Evaluation of Alkasite Restorative Material Versus Glass Ionomer Cement
Launched by CAIRO UNIVERSITY · Dec 23, 2023
Trial Information
Current as of September 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two types of materials used to fill cavities in children's teeth: Alkasite restorative material and glass ionomer cement. The goal is to see how well each material works in treating tooth decay in primary molars, which are the back teeth in young children. The trial is not yet recruiting participants, but when it starts, it will focus on children aged 5 to 7 years who have cavities in their primary molars that do not involve the pulp (the sensitive part of the tooth).
To be eligible for the trial, children must be able to cooperate during the dental procedure and must not have any serious health issues. Parents who are interested will need to provide consent for their child's participation. If a child is chosen for the study, they can expect to receive one of the two types of dental fillings, and their progress will be monitored to evaluate how well the filling works over time. This study aims to help improve dental treatments for young children with tooth decay.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children having carious primary molars without pulp exposure and normal radiograph.
- • 2. Children between age 5 and 7 years. 3. Both male and female are included. 4. Cooperative Children.
- Exclusion Criteria:
- • 1. Patients with systemic diseases. 2. Parent refuse to participate.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sherien Ezz Eldin, Professor
Study Director
cairo university faculty of pediatric dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported